nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP2C8—Levothyroxine—hypothyroidism	0.0828	0.42	CbGbCtD
Tretinoin—CYP2C8—Liotrix—hypothyroidism	0.0808	0.41	CbGbCtD
Tretinoin—NR0B1—seminiferous tubule of testis—hypothyroidism	0.0373	0.148	CbGeAlD
Tretinoin—CYP3A4—Levothyroxine—hypothyroidism	0.0336	0.17	CbGbCtD
Tretinoin—Benign intracranial hypertension—Dextrothyroxine—hypothyroidism	0.00989	0.0347	CcSEcCtD
Tretinoin—Benign intracranial hypertension—Levothyroxine—hypothyroidism	0.00989	0.0347	CcSEcCtD
Tretinoin—Benign intracranial hypertension—Liotrix—hypothyroidism	0.00728	0.0255	CcSEcCtD
Tretinoin—Renal tubular necrosis—Liotrix—hypothyroidism	0.00599	0.021	CcSEcCtD
Tretinoin—Clotting—Liotrix—hypothyroidism	0.00599	0.021	CcSEcCtD
Tretinoin—RARG—tongue—hypothyroidism	0.00551	0.0219	CbGeAlD
Tretinoin—Phlebitis—Liothyronine—hypothyroidism	0.00499	0.0175	CcSEcCtD
Tretinoin—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00474	0.0166	CcSEcCtD
Tretinoin—RARB—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00464	0.0175	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00445	0.0167	CbGpPWpGaD
Tretinoin—RXRB—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00445	0.0167	CbGpPWpGaD
Tretinoin—RARRES1—adrenal cortex—hypothyroidism	0.00443	0.0176	CbGeAlD
Tretinoin—RARRES1—heart—hypothyroidism	0.00429	0.017	CbGeAlD
Tretinoin—RARG—Nuclear Receptors—THRB—hypothyroidism	0.00422	0.0159	CbGpPWpGaD
Tretinoin—NR0B1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00414	0.0156	CbGpPWpGaD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.00398	0.0149	CbGpPWpGaD
Tretinoin—Acidosis—Liotrix—hypothyroidism	0.00386	0.0136	CcSEcCtD
Tretinoin—RXRG—Nuclear Receptors—THRB—hypothyroidism	0.00386	0.0145	CbGpPWpGaD
Tretinoin—NR0B1—adrenal cortex—hypothyroidism	0.00382	0.0152	CbGeAlD
Tretinoin—RARB—Nuclear Receptors—THRB—hypothyroidism	0.00379	0.0142	CbGpPWpGaD
Tretinoin—RXRB—Nuclear Receptors—THRB—hypothyroidism	0.00363	0.0136	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptors—THRB—hypothyroidism	0.00363	0.0136	CbGpPWpGaD
Tretinoin—RARRES1—pituitary gland—hypothyroidism	0.00358	0.0142	CbGeAlD
Tretinoin—Fluid overload—Liotrix—hypothyroidism	0.00344	0.0121	CcSEcCtD
Tretinoin—RARG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00334	0.0125	CbGpPWpGaD
Tretinoin—ALDH1A2—heart—hypothyroidism	0.00329	0.0131	CbGeAlD
Tretinoin—CRABP1—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.00329	0.0123	CbGpPWpGaD
Tretinoin—CRABP2—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.00329	0.0123	CbGpPWpGaD
Tretinoin—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00326	0.0115	CcSEcCtD
Tretinoin—Myocardial infarction—Liothyronine—hypothyroidism	0.00325	0.0114	CcSEcCtD
Tretinoin—RARRES1—adrenal gland—hypothyroidism	0.0032	0.0127	CbGeAlD
Tretinoin—NR0B1—gonad—hypothyroidism	0.00316	0.0126	CbGeAlD
Tretinoin—ALDH1A2—cardiovascular system—hypothyroidism	0.0031	0.0123	CbGeAlD
Tretinoin—RARRES1—thyroid gland—hypothyroidism	0.00309	0.0123	CbGeAlD
Tretinoin—NR0B1—pituitary gland—hypothyroidism	0.00308	0.0123	CbGeAlD
Tretinoin—RXRG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00305	0.0115	CbGpPWpGaD
Tretinoin—Cyanosis—Liotrix—hypothyroidism	0.00302	0.0106	CcSEcCtD
Tretinoin—RARB—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00299	0.0112	CbGpPWpGaD
Tretinoin—RARRES1—female gonad—hypothyroidism	0.00298	0.0119	CbGeAlD
Tretinoin—RXRA—Nuclear Receptors—THRA—hypothyroidism	0.00294	0.011	CbGpPWpGaD
Tretinoin—RXRB—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00287	0.0108	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00287	0.0108	CbGpPWpGaD
Tretinoin—Wheezing—Levothyroxine—hypothyroidism	0.00282	0.00991	CcSEcCtD
Tretinoin—Wheezing—Dextrothyroxine—hypothyroidism	0.00282	0.00991	CcSEcCtD
Tretinoin—ALDH1A2—gonad—hypothyroidism	0.00282	0.0112	CbGeAlD
Tretinoin—NR0B1—adrenal gland—hypothyroidism	0.00276	0.0109	CbGeAlD
Tretinoin—ALDH1A2—pituitary gland—hypothyroidism	0.00275	0.0109	CbGeAlD
Tretinoin—Coagulopathy—Liotrix—hypothyroidism	0.00275	0.00964	CcSEcCtD
Tretinoin—CRABP1—gonad—hypothyroidism	0.00272	0.0108	CbGeAlD
Tretinoin—CYP2C9—urine—hypothyroidism	0.0027	0.0107	CbGeAlD
Tretinoin—Tingling sensation—Liotrix—hypothyroidism	0.00266	0.00934	CcSEcCtD
Tretinoin—Coma—Levothyroxine—hypothyroidism	0.00266	0.00932	CcSEcCtD
Tretinoin—Coma—Dextrothyroxine—hypothyroidism	0.00266	0.00932	CcSEcCtD
Tretinoin—Arrhythmia—Liothyronine—hypothyroidism	0.00266	0.00932	CcSEcCtD
Tretinoin—CRABP1—pituitary gland—hypothyroidism	0.00265	0.0105	CbGeAlD
Tretinoin—RARRES1—testis—hypothyroidism	0.00265	0.0105	CbGeAlD
Tretinoin—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—NKX2-5—hypothyroidism	0.0026	0.00976	CbGpPWpGaD
Tretinoin—NR0B1—female gonad—hypothyroidism	0.00257	0.0102	CbGeAlD
Tretinoin—RARB—heart—hypothyroidism	0.00257	0.0102	CbGeAlD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00256	0.00963	CbGpPWpGaD
Tretinoin—RXRG—heart—hypothyroidism	0.00251	0.00997	CbGeAlD
Tretinoin—ALDH1A1—adrenal cortex—hypothyroidism	0.00247	0.00983	CbGeAlD
Tretinoin—CRABP2—gonad—hypothyroidism	0.00246	0.00977	CbGeAlD
Tretinoin—ALDH1A2—adrenal gland—hypothyroidism	0.00246	0.00976	CbGeAlD
Tretinoin—ALDH1A2—blood—hypothyroidism	0.00246	0.00975	CbGeAlD
Tretinoin—Tenderness—Liotrix—hypothyroidism	0.00245	0.0086	CcSEcCtD
Tretinoin—CRABP2—pituitary gland—hypothyroidism	0.0024	0.00953	CbGeAlD
Tretinoin—ALDH1A1—heart—hypothyroidism	0.00239	0.0095	CbGeAlD
Tretinoin—ALDH1A2—thyroid gland—hypothyroidism	0.00237	0.00941	CbGeAlD
Tretinoin—RXRG—cardiovascular system—hypothyroidism	0.00237	0.00941	CbGeAlD
Tretinoin—RXRB—heart—hypothyroidism	0.00236	0.00937	CbGeAlD
Tretinoin—Cellulitis—Liotrix—hypothyroidism	0.00235	0.00825	CcSEcCtD
Tretinoin—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00233	0.00817	CcSEcCtD
Tretinoin—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00233	0.00817	CcSEcCtD
Tretinoin—RXRA—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00232	0.00872	CbGpPWpGaD
Tretinoin—ALDH1A2—female gonad—hypothyroidism	0.00229	0.0091	CbGeAlD
Tretinoin—CRABP1—thyroid gland—hypothyroidism	0.00229	0.00908	CbGeAlD
Tretinoin—NR0B1—testis—hypothyroidism	0.00228	0.00905	CbGeAlD
Tretinoin—Ulcer—Liotrix—hypothyroidism	0.00226	0.00794	CcSEcCtD
Tretinoin—ALDH1A1—cardiovascular system—hypothyroidism	0.00226	0.00897	CbGeAlD
Tretinoin—Hypertension—Liothyronine—hypothyroidism	0.00223	0.00784	CcSEcCtD
Tretinoin—Cardiac failure—Levothyroxine—hypothyroidism	0.00216	0.00759	CcSEcCtD
Tretinoin—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00216	0.00759	CcSEcCtD
Tretinoin—CRABP2—adrenal gland—hypothyroidism	0.00214	0.00851	CbGeAlD
Tretinoin—CRABP2—blood—hypothyroidism	0.00214	0.00851	CbGeAlD
Tretinoin—RXRG—pituitary gland—hypothyroidism	0.0021	0.00833	CbGeAlD
Tretinoin—RARG—heart—hypothyroidism	0.00209	0.00832	CbGeAlD
Tretinoin—Affect lability—Levothyroxine—hypothyroidism	0.00208	0.00729	CcSEcCtD
Tretinoin—Affect lability—Dextrothyroxine—hypothyroidism	0.00208	0.00729	CcSEcCtD
Tretinoin—Wheezing—Liotrix—hypothyroidism	0.00208	0.00729	CcSEcCtD
Tretinoin—CRABP2—thyroid gland—hypothyroidism	0.00207	0.00821	CbGeAlD
Tretinoin—CYP3A4—urine—hypothyroidism	0.00206	0.00819	CbGeAlD
Tretinoin—Tachycardia—Liothyronine—hypothyroidism	0.00206	0.00723	CcSEcCtD
Tretinoin—ALDH1A1—gonad—hypothyroidism	0.00205	0.00814	CbGeAlD
Tretinoin—ALDH1A2—testis—hypothyroidism	0.00203	0.00807	CbGeAlD
Tretinoin—Irritability—Levothyroxine—hypothyroidism	0.00201	0.00707	CcSEcCtD
Tretinoin—Irritability—Dextrothyroxine—hypothyroidism	0.00201	0.00707	CcSEcCtD
Tretinoin—Cardiac arrest—Levothyroxine—hypothyroidism	0.00201	0.00704	CcSEcCtD
Tretinoin—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00201	0.00704	CcSEcCtD
Tretinoin—Mood swings—Dextrothyroxine—hypothyroidism	0.002	0.00702	CcSEcCtD
Tretinoin—Mood swings—Levothyroxine—hypothyroidism	0.002	0.00702	CcSEcCtD
Tretinoin—ALDH1A1—pituitary gland—hypothyroidism	0.002	0.00794	CbGeAlD
Tretinoin—CRABP2—female gonad—hypothyroidism	0.002	0.00794	CbGeAlD
Tretinoin—RXRA—female gonad—hypothyroidism	0.00199	0.0079	CbGeAlD
Tretinoin—Hypotension—Liothyronine—hypothyroidism	0.00197	0.00693	CcSEcCtD
Tretinoin—RARA—heart—hypothyroidism	0.00197	0.00782	CbGeAlD
Tretinoin—Dehydration—Dextrothyroxine—hypothyroidism	0.00196	0.00689	CcSEcCtD
Tretinoin—Dehydration—Levothyroxine—hypothyroidism	0.00196	0.00689	CcSEcCtD
Tretinoin—CRABP1—testis—hypothyroidism	0.00196	0.00778	CbGeAlD
Tretinoin—Coma—Liotrix—hypothyroidism	0.00195	0.00686	CcSEcCtD
Tretinoin—ALDH1A2—liver—hypothyroidism	0.00192	0.00763	CbGeAlD
Tretinoin—RARB—adrenal gland—hypothyroidism	0.00192	0.00761	CbGeAlD
Tretinoin—Lightheadedness—Liotrix—hypothyroidism	0.00191	0.00672	CcSEcCtD
Tretinoin—RXRA—Nuclear Receptors—THRB—hypothyroidism	0.00189	0.00711	CbGpPWpGaD
Tretinoin—ALDH1A2—cerebellum—hypothyroidism	0.00188	0.00745	CbGeAlD
Tretinoin—RXRG—adrenal gland—hypothyroidism	0.00187	0.00744	CbGeAlD
Tretinoin—Sepsis—Liotrix—hypothyroidism	0.00186	0.00651	CcSEcCtD
Tretinoin—CYP4A11—liver—hypothyroidism	0.00185	0.00736	CbGeAlD
Tretinoin—RARB—thyroid gland—hypothyroidism	0.00185	0.00735	CbGeAlD
Tretinoin—Dysphagia—Levothyroxine—hypothyroidism	0.00182	0.0064	CcSEcCtD
Tretinoin—Dysphagia—Dextrothyroxine—hypothyroidism	0.00182	0.0064	CcSEcCtD
Tretinoin—CRABP1—cerebellum—hypothyroidism	0.00181	0.00719	CbGeAlD
Tretinoin—RXRG—thyroid gland—hypothyroidism	0.00181	0.00718	CbGeAlD
Tretinoin—Phlebitis—Liotrix—hypothyroidism	0.0018	0.00632	CcSEcCtD
Tretinoin—RARB—female gonad—hypothyroidism	0.00179	0.0071	CbGeAlD
Tretinoin—ALDH1A1—adrenal gland—hypothyroidism	0.00179	0.00709	CbGeAlD
Tretinoin—ALDH1A1—blood—hypothyroidism	0.00179	0.00709	CbGeAlD
Tretinoin—Sweating increased—Dextrothyroxine—hypothyroidism	0.00178	0.00624	CcSEcCtD
Tretinoin—Sweating increased—Levothyroxine—hypothyroidism	0.00178	0.00624	CcSEcCtD
Tretinoin—CRABP2—testis—hypothyroidism	0.00177	0.00704	CbGeAlD
Tretinoin—RXRB—adrenal gland—hypothyroidism	0.00176	0.007	CbGeAlD
Tretinoin—Swelling—Liotrix—hypothyroidism	0.00176	0.00618	CcSEcCtD
Tretinoin—ALDH1A1—thyroid gland—hypothyroidism	0.00172	0.00684	CbGeAlD
Tretinoin—NR0B1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00172	0.00647	CbGpPWpGaD
Tretinoin—Cardiac failure congestive—Liotrix—hypothyroidism	0.00171	0.00601	CcSEcCtD
Tretinoin—RXRB—thyroid gland—hypothyroidism	0.0017	0.00675	CbGeAlD
Tretinoin—RARA—gonad—hypothyroidism	0.00169	0.0067	CbGeAlD
Tretinoin—Renal failure acute—Liotrix—hypothyroidism	0.00168	0.0059	CcSEcCtD
Tretinoin—Body temperature increased—Liothyronine—hypothyroidism	0.00167	0.00586	CcSEcCtD
Tretinoin—RXRA—liver—hypothyroidism	0.00167	0.00663	CbGeAlD
Tretinoin—ALDH1A1—female gonad—hypothyroidism	0.00166	0.00661	CbGeAlD
Tretinoin—Weight decreased—Dextrothyroxine—hypothyroidism	0.00165	0.00579	CcSEcCtD
Tretinoin—Weight decreased—Levothyroxine—hypothyroidism	0.00165	0.00579	CcSEcCtD
Tretinoin—RARA—pituitary gland—hypothyroidism	0.00165	0.00654	CbGeAlD
Tretinoin—RXRB—female gonad—hypothyroidism	0.00164	0.00652	CbGeAlD
Tretinoin—CRABP2—cerebellum—hypothyroidism	0.00164	0.0065	CbGeAlD
Tretinoin—Renal impairment—Liotrix—hypothyroidism	0.00163	0.00572	CcSEcCtD
Tretinoin—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.0016	0.00563	CcSEcCtD
Tretinoin—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.0016	0.00563	CcSEcCtD
Tretinoin—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00159	0.0056	CcSEcCtD
Tretinoin—Myocardial infarction—Levothyroxine—hypothyroidism	0.00159	0.0056	CcSEcCtD
Tretinoin—Cardiac failure—Liotrix—hypothyroidism	0.00159	0.00558	CcSEcCtD
Tretinoin—Cerebrovascular accident—Liotrix—hypothyroidism	0.00158	0.00556	CcSEcCtD
Tretinoin—RARG—adrenal gland—hypothyroidism	0.00156	0.00621	CbGeAlD
Tretinoin—RARG—blood—hypothyroidism	0.00156	0.00621	CbGeAlD
Tretinoin—Sweating—Levothyroxine—hypothyroidism	0.00156	0.00547	CcSEcCtD
Tretinoin—Sweating—Dextrothyroxine—hypothyroidism	0.00156	0.00547	CcSEcCtD
Tretinoin—RXRG—testis—hypothyroidism	0.00155	0.00615	CbGeAlD
Tretinoin—NR0B1—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.00154	0.00579	CbGpPWpGaD
Tretinoin—Affect lability—Liotrix—hypothyroidism	0.00153	0.00536	CcSEcCtD
Tretinoin—RARG—thyroid gland—hypothyroidism	0.00151	0.00599	CbGeAlD
Tretinoin—RARB—liver—hypothyroidism	0.0015	0.00595	CbGeAlD
Tretinoin—RXRA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0015	0.00562	CbGpPWpGaD
Tretinoin—Irritability—Liotrix—hypothyroidism	0.00148	0.0052	CcSEcCtD
Tretinoin—ALDH1A1—testis—hypothyroidism	0.00148	0.00587	CbGeAlD
Tretinoin—Cardiac arrest—Liotrix—hypothyroidism	0.00148	0.00518	CcSEcCtD
Tretinoin—Mood swings—Liotrix—hypothyroidism	0.00147	0.00516	CcSEcCtD
Tretinoin—RARA—adrenal gland—hypothyroidism	0.00147	0.00584	CbGeAlD
Tretinoin—RARA—blood—hypothyroidism	0.00147	0.00584	CbGeAlD
Tretinoin—RARB—cerebellum—hypothyroidism	0.00146	0.00581	CbGeAlD
Tretinoin—RARG—female gonad—hypothyroidism	0.00146	0.00579	CbGeAlD
Tretinoin—RXRB—testis—hypothyroidism	0.00146	0.00579	CbGeAlD
Tretinoin—Blood creatinine increased—Liotrix—hypothyroidism	0.00145	0.0051	CcSEcCtD
Tretinoin—Dehydration—Liotrix—hypothyroidism	0.00144	0.00507	CcSEcCtD
Tretinoin—RARA—thyroid gland—hypothyroidism	0.00142	0.00563	CbGeAlD
Tretinoin—ALDH1A1—liver—hypothyroidism	0.0014	0.00555	CbGeAlD
Tretinoin—RARG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00139	0.00522	CbGpPWpGaD
Tretinoin—RXRB—liver—hypothyroidism	0.00138	0.00547	CbGeAlD
Tretinoin—RARA—female gonad—hypothyroidism	0.00137	0.00544	CbGeAlD
Tretinoin—ALDH1A1—cerebellum—hypothyroidism	0.00136	0.00542	CbGeAlD
Tretinoin—Flushing—Dextrothyroxine—hypothyroidism	0.00136	0.00476	CcSEcCtD
Tretinoin—Flushing—Levothyroxine—hypothyroidism	0.00136	0.00476	CcSEcCtD
Tretinoin—Abdominal distension—Liotrix—hypothyroidism	0.00135	0.00474	CcSEcCtD
Tretinoin—RXRB—cerebellum—hypothyroidism	0.00134	0.00534	CbGeAlD
Tretinoin—Dysphagia—Liotrix—hypothyroidism	0.00134	0.00471	CcSEcCtD
Tretinoin—Bronchospasm—Liotrix—hypothyroidism	0.00132	0.00463	CcSEcCtD
Tretinoin—Sweating increased—Liotrix—hypothyroidism	0.00131	0.00459	CcSEcCtD
Tretinoin—Arrhythmia—Levothyroxine—hypothyroidism	0.0013	0.00458	CcSEcCtD
Tretinoin—Arrhythmia—Dextrothyroxine—hypothyroidism	0.0013	0.00458	CcSEcCtD
Tretinoin—RARG—testis—hypothyroidism	0.00129	0.00514	CbGeAlD
Tretinoin—Alopecia—Dextrothyroxine—hypothyroidism	0.00129	0.00453	CcSEcCtD
Tretinoin—Alopecia—Levothyroxine—hypothyroidism	0.00129	0.00453	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00127	0.00477	CbGpPWpGaD
Tretinoin—Tension—Dextrothyroxine—hypothyroidism	0.00125	0.00438	CcSEcCtD
Tretinoin—Tension—Levothyroxine—hypothyroidism	0.00125	0.00438	CcSEcCtD
Tretinoin—RARB—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00125	0.00468	CbGpPWpGaD
Tretinoin—Nervousness—Levothyroxine—hypothyroidism	0.00123	0.00433	CcSEcCtD
Tretinoin—Nervousness—Dextrothyroxine—hypothyroidism	0.00123	0.00433	CcSEcCtD
Tretinoin—CYP2C18—liver—hypothyroidism	0.00123	0.00488	CbGeAlD
Tretinoin—RARA—testis—hypothyroidism	0.00122	0.00483	CbGeAlD
Tretinoin—Weight decreased—Liotrix—hypothyroidism	0.00121	0.00426	CcSEcCtD
Tretinoin—RARG—cerebellum—hypothyroidism	0.00119	0.00474	CbGeAlD
Tretinoin—RARA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00119	0.00448	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00119	0.00448	CbGpPWpGaD
Tretinoin—Tremor—Dextrothyroxine—hypothyroidism	0.00119	0.00418	CcSEcCtD
Tretinoin—Tremor—Levothyroxine—hypothyroidism	0.00119	0.00418	CcSEcCtD
Tretinoin—Acute coronary syndrome—Liotrix—hypothyroidism	0.00118	0.00414	CcSEcCtD
Tretinoin—Renal failure—Liotrix—hypothyroidism	0.00118	0.00413	CcSEcCtD
Tretinoin—Myocardial infarction—Liotrix—hypothyroidism	0.00117	0.00412	CcSEcCtD
Tretinoin—Agitation—Dextrothyroxine—hypothyroidism	0.00117	0.0041	CcSEcCtD
Tretinoin—Agitation—Levothyroxine—hypothyroidism	0.00117	0.0041	CcSEcCtD
Tretinoin—CYP3A7—liver—hypothyroidism	0.00117	0.00464	CbGeAlD
Tretinoin—RARA—liver—hypothyroidism	0.00115	0.00456	CbGeAlD
Tretinoin—Sweating—Liotrix—hypothyroidism	0.00115	0.00403	CcSEcCtD
Tretinoin—Palpitations—Levothyroxine—hypothyroidism	0.00112	0.00394	CcSEcCtD
Tretinoin—Palpitations—Dextrothyroxine—hypothyroidism	0.00112	0.00394	CcSEcCtD
Tretinoin—RARA—cerebellum—hypothyroidism	0.00112	0.00446	CbGeAlD
Tretinoin—NR0B1—Generic Transcription Pathway—THRA—hypothyroidism	0.00111	0.00417	CbGpPWpGaD
Tretinoin—Convulsion—Dextrothyroxine—hypothyroidism	0.0011	0.00386	CcSEcCtD
Tretinoin—Convulsion—Levothyroxine—hypothyroidism	0.0011	0.00386	CcSEcCtD
Tretinoin—Arthralgia—Dextrothyroxine—hypothyroidism	0.00108	0.0038	CcSEcCtD
Tretinoin—Arthralgia—Levothyroxine—hypothyroidism	0.00108	0.0038	CcSEcCtD
Tretinoin—Anxiety—Dextrothyroxine—hypothyroidism	0.00108	0.00378	CcSEcCtD
Tretinoin—Anxiety—Levothyroxine—hypothyroidism	0.00108	0.00378	CcSEcCtD
Tretinoin—Hypoaesthesia—Liotrix—hypothyroidism	0.00107	0.00375	CcSEcCtD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00105	0.00396	CbGpPWpGaD
Tretinoin—Confusional state—Levothyroxine—hypothyroidism	0.00105	0.00367	CcSEcCtD
Tretinoin—Confusional state—Dextrothyroxine—hypothyroidism	0.00105	0.00367	CcSEcCtD
Tretinoin—CYP4A11—NRF2 pathway—SLC5A7—hypothyroidism	0.00103	0.00386	CbGpPWpGaD
Tretinoin—Shock—Levothyroxine—hypothyroidism	0.00102	0.00358	CcSEcCtD
Tretinoin—Shock—Dextrothyroxine—hypothyroidism	0.00102	0.00358	CcSEcCtD
Tretinoin—Tachycardia—Levothyroxine—hypothyroidism	0.00101	0.00355	CcSEcCtD
Tretinoin—Tachycardia—Dextrothyroxine—hypothyroidism	0.00101	0.00355	CcSEcCtD
Tretinoin—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.001	0.00352	CcSEcCtD
Tretinoin—Hyperhidrosis—Levothyroxine—hypothyroidism	0.001	0.00352	CcSEcCtD
Tretinoin—Flushing—Liotrix—hypothyroidism	0.000997	0.0035	CcSEcCtD
Tretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.000995	0.00374	CbGpPWpGaD
Tretinoin—CYP3A7-CYP3A51P—liver—hypothyroidism	0.000993	0.00394	CbGeAlD
Tretinoin—Arrhythmia—Liotrix—hypothyroidism	0.000959	0.00337	CcSEcCtD
Tretinoin—Alopecia—Liotrix—hypothyroidism	0.000949	0.00333	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000945	0.00332	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000945	0.00332	CcSEcCtD
Tretinoin—Insomnia—Dextrothyroxine—hypothyroidism	0.000938	0.00329	CcSEcCtD
Tretinoin—Insomnia—Levothyroxine—hypothyroidism	0.000938	0.00329	CcSEcCtD
Tretinoin—ALDH1A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00093	0.0035	CbGpPWpGaD
Tretinoin—Dyspnoea—Levothyroxine—hypothyroidism	0.000925	0.00325	CcSEcCtD
Tretinoin—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000925	0.00325	CcSEcCtD
Tretinoin—Flatulence—Liotrix—hypothyroidism	0.000921	0.00323	CcSEcCtD
Tretinoin—Tension—Liotrix—hypothyroidism	0.000917	0.00322	CcSEcCtD
Tretinoin—Nervousness—Liotrix—hypothyroidism	0.000908	0.00319	CcSEcCtD
Tretinoin—RARG—Generic Transcription Pathway—THRA—hypothyroidism	0.000895	0.00336	CbGpPWpGaD
Tretinoin—Fatigue—Levothyroxine—hypothyroidism	0.000894	0.00314	CcSEcCtD
Tretinoin—Fatigue—Dextrothyroxine—hypothyroidism	0.000894	0.00314	CcSEcCtD
Tretinoin—Vision blurred—Liotrix—hypothyroidism	0.000881	0.00309	CcSEcCtD
Tretinoin—Tremor—Liotrix—hypothyroidism	0.000876	0.00307	CcSEcCtD
Tretinoin—Agitation—Liotrix—hypothyroidism	0.000859	0.00302	CcSEcCtD
Tretinoin—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000855	0.003	CcSEcCtD
Tretinoin—Feeling abnormal—Levothyroxine—hypothyroidism	0.000855	0.003	CcSEcCtD
Tretinoin—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000848	0.00298	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000848	0.00298	CcSEcCtD
Tretinoin—Syncope—Liotrix—hypothyroidism	0.000838	0.00294	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—ZNF764—hypothyroidism	0.000829	0.00311	CbGpPWpGaD
Tretinoin—Palpitations—Liotrix—hypothyroidism	0.000826	0.0029	CcSEcCtD
Tretinoin—Urticaria—Levothyroxine—hypothyroidism	0.000824	0.00289	CcSEcCtD
Tretinoin—Urticaria—Dextrothyroxine—hypothyroidism	0.000824	0.00289	CcSEcCtD
Tretinoin—Loss of consciousness—Liotrix—hypothyroidism	0.000822	0.00288	CcSEcCtD
Tretinoin—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00082	0.00288	CcSEcCtD
Tretinoin—Body temperature increased—Levothyroxine—hypothyroidism	0.00082	0.00288	CcSEcCtD
Tretinoin—Abdominal pain—Levothyroxine—hypothyroidism	0.00082	0.00288	CcSEcCtD
Tretinoin—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00082	0.00288	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—THRA—hypothyroidism	0.000818	0.00307	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—SLC5A7—hypothyroidism	0.000816	0.00306	CbGpPWpGaD
Tretinoin—CYP2A6—liver—hypothyroidism	0.000811	0.00322	CbGeAlD
Tretinoin—Convulsion—Liotrix—hypothyroidism	0.00081	0.00284	CcSEcCtD
Tretinoin—Hypertension—Liotrix—hypothyroidism	0.000807	0.00283	CcSEcCtD
Tretinoin—RARB—Generic Transcription Pathway—THRA—hypothyroidism	0.000802	0.00301	CbGpPWpGaD
Tretinoin—Arthralgia—Liotrix—hypothyroidism	0.000796	0.00279	CcSEcCtD
Tretinoin—Chest pain—Liotrix—hypothyroidism	0.000796	0.00279	CcSEcCtD
Tretinoin—Anxiety—Liotrix—hypothyroidism	0.000793	0.00278	CcSEcCtD
Tretinoin—CYP2A6—cerebellum—hypothyroidism	0.000792	0.00315	CbGeAlD
Tretinoin—NR0B1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000791	0.00297	CbGpPWpGaD
Tretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.00077	0.00289	CbGpPWpGaD
Tretinoin—Confusional state—Liotrix—hypothyroidism	0.000769	0.0027	CcSEcCtD
Tretinoin—RARA—Generic Transcription Pathway—THRA—hypothyroidism	0.000769	0.00289	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—THRA—hypothyroidism	0.000769	0.00289	CbGpPWpGaD
Tretinoin—Oedema—Liotrix—hypothyroidism	0.000763	0.00268	CcSEcCtD
Tretinoin—Anaphylactic shock—Liotrix—hypothyroidism	0.000763	0.00268	CcSEcCtD
Tretinoin—Infection—Liotrix—hypothyroidism	0.000758	0.00266	CcSEcCtD
Tretinoin—Shock—Liotrix—hypothyroidism	0.000751	0.00263	CcSEcCtD
Tretinoin—RXRA—Endogenous sterols—POMC—hypothyroidism	0.000748	0.00281	CbGpPWpGaD
Tretinoin—Tachycardia—Liotrix—hypothyroidism	0.000745	0.00261	CcSEcCtD
Tretinoin—Asthenia—Dextrothyroxine—hypothyroidism	0.000744	0.00261	CcSEcCtD
Tretinoin—Asthenia—Levothyroxine—hypothyroidism	0.000744	0.00261	CcSEcCtD
Tretinoin—Hyperhidrosis—Liotrix—hypothyroidism	0.000738	0.00259	CcSEcCtD
Tretinoin—Pruritus—Levothyroxine—hypothyroidism	0.000734	0.00258	CcSEcCtD
Tretinoin—Pruritus—Dextrothyroxine—hypothyroidism	0.000734	0.00258	CcSEcCtD
Tretinoin—Anorexia—Liotrix—hypothyroidism	0.000727	0.00255	CcSEcCtD
Tretinoin—CYP2B6—adrenal cortex—hypothyroidism	0.000724	0.00287	CbGeAlD
Tretinoin—CYP1A1—heart—hypothyroidism	0.00072	0.00286	CbGeAlD
Tretinoin—NR0B1—Generic Transcription Pathway—THRB—hypothyroidism	0.000715	0.00269	CbGpPWpGaD
Tretinoin—Hypotension—Liotrix—hypothyroidism	0.000713	0.0025	CcSEcCtD
Tretinoin—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00071	0.00249	CcSEcCtD
Tretinoin—Diarrhoea—Levothyroxine—hypothyroidism	0.00071	0.00249	CcSEcCtD
Tretinoin—CYP2B6—heart—hypothyroidism	0.0007	0.00278	CbGeAlD
Tretinoin—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000695	0.00244	CcSEcCtD
Tretinoin—CYP2C9—heart—hypothyroidism	0.000693	0.00275	CbGeAlD
Tretinoin—Insomnia—Liotrix—hypothyroidism	0.00069	0.00242	CcSEcCtD
Tretinoin—Paraesthesia—Liotrix—hypothyroidism	0.000685	0.0024	CcSEcCtD
Tretinoin—Dyspnoea—Liotrix—hypothyroidism	0.00068	0.00239	CcSEcCtD
Tretinoin—RARG—Gene Expression—ZNF764—hypothyroidism	0.000668	0.00251	CbGpPWpGaD
Tretinoin—Decreased appetite—Liotrix—hypothyroidism	0.000663	0.00233	CcSEcCtD
Tretinoin—CYP2B6—cardiovascular system—hypothyroidism	0.00066	0.00262	CbGeAlD
Tretinoin—Vomiting—Levothyroxine—hypothyroidism	0.00066	0.00231	CcSEcCtD
Tretinoin—Vomiting—Dextrothyroxine—hypothyroidism	0.00066	0.00231	CcSEcCtD
Tretinoin—Fatigue—Liotrix—hypothyroidism	0.000658	0.00231	CcSEcCtD
Tretinoin—Rash—Levothyroxine—hypothyroidism	0.000654	0.0023	CcSEcCtD
Tretinoin—Rash—Dextrothyroxine—hypothyroidism	0.000654	0.0023	CcSEcCtD
Tretinoin—CYP2C9—cardiovascular system—hypothyroidism	0.000654	0.0026	CbGeAlD
Tretinoin—Dermatitis—Levothyroxine—hypothyroidism	0.000653	0.00229	CcSEcCtD
Tretinoin—Dermatitis—Dextrothyroxine—hypothyroidism	0.000653	0.00229	CcSEcCtD
Tretinoin—Constipation—Liotrix—hypothyroidism	0.000653	0.00229	CcSEcCtD
Tretinoin—CYP2C8—pituitary gland—hypothyroidism	0.000652	0.00259	CbGeAlD
Tretinoin—Headache—Dextrothyroxine—hypothyroidism	0.00065	0.00228	CcSEcCtD
Tretinoin—Headache—Levothyroxine—hypothyroidism	0.00065	0.00228	CcSEcCtD
Tretinoin—RARG—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000637	0.00239	CbGpPWpGaD
Tretinoin—Feeling abnormal—Liotrix—hypothyroidism	0.000629	0.00221	CcSEcCtD
Tretinoin—Gastrointestinal pain—Liotrix—hypothyroidism	0.000624	0.00219	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000622	0.00234	CbGpPWpGaD
Tretinoin—Nausea—Dextrothyroxine—hypothyroidism	0.000616	0.00216	CcSEcCtD
Tretinoin—Nausea—Levothyroxine—hypothyroidism	0.000616	0.00216	CcSEcCtD
Tretinoin—RXRG—Gene Expression—ZNF764—hypothyroidism	0.000611	0.0023	CbGpPWpGaD
Tretinoin—Urticaria—Liotrix—hypothyroidism	0.000606	0.00213	CcSEcCtD
Tretinoin—Abdominal pain—Liotrix—hypothyroidism	0.000603	0.00212	CcSEcCtD
Tretinoin—Body temperature increased—Liotrix—hypothyroidism	0.000603	0.00212	CcSEcCtD
Tretinoin—RARB—Gene Expression—ZNF764—hypothyroidism	0.000599	0.00225	CbGpPWpGaD
Tretinoin—CYP2B6—gonad—hypothyroidism	0.000599	0.00238	CbGeAlD
Tretinoin—CRABP2—Metabolism—IYD—hypothyroidism	0.000583	0.00219	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—IYD—hypothyroidism	0.000583	0.00219	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—IYD—hypothyroidism	0.000583	0.00219	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000583	0.00219	CbGpPWpGaD
Tretinoin—CYP2C8—blood—hypothyroidism	0.000582	0.00231	CbGeAlD
Tretinoin—RARG—Generic Transcription Pathway—THRB—hypothyroidism	0.000576	0.00217	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—ZNF764—hypothyroidism	0.000575	0.00216	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—ZNF764—hypothyroidism	0.000575	0.00216	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000572	0.00215	CbGpPWpGaD
Tretinoin—Hypersensitivity—Liotrix—hypothyroidism	0.000562	0.00197	CcSEcCtD
Tretinoin—RXRA—Circadian Clock—AVP—hypothyroidism	0.00056	0.00211	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000548	0.00206	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000548	0.00206	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—SLC5A7—hypothyroidism	0.000548	0.00206	CbGpPWpGaD
Tretinoin—Asthenia—Liotrix—hypothyroidism	0.000547	0.00192	CcSEcCtD
Tretinoin—Pruritus—Liotrix—hypothyroidism	0.00054	0.00189	CcSEcCtD
Tretinoin—CYP1A1—blood—hypothyroidism	0.000537	0.00213	CbGeAlD
Tretinoin—NR0B1—Gene Expression—THRA—hypothyroidism	0.000534	0.00201	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—THRB—hypothyroidism	0.000527	0.00198	CbGpPWpGaD
Tretinoin—CYP3A5—blood—hypothyroidism	0.000525	0.00209	CbGeAlD
Tretinoin—CYP2B6—adrenal gland—hypothyroidism	0.000522	0.00207	CbGeAlD
Tretinoin—CYP2B6—blood—hypothyroidism	0.000522	0.00207	CbGeAlD
Tretinoin—Diarrhoea—Liotrix—hypothyroidism	0.000522	0.00183	CcSEcCtD
Tretinoin—CYP1A1—thyroid gland—hypothyroidism	0.000519	0.00206	CbGeAlD
Tretinoin—CYP2C9—blood—hypothyroidism	0.000517	0.00205	CbGeAlD
Tretinoin—RARB—Generic Transcription Pathway—THRB—hypothyroidism	0.000517	0.00194	CbGpPWpGaD
Tretinoin—Dizziness—Liotrix—hypothyroidism	0.000505	0.00177	CcSEcCtD
Tretinoin—CYP1A1—female gonad—hypothyroidism	0.000501	0.00199	CbGeAlD
Tretinoin—CRABP2—Metabolism—ATP5O—hypothyroidism	0.000496	0.00186	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ATP5O—hypothyroidism	0.000496	0.00186	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ATP5O—hypothyroidism	0.000496	0.00186	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—THRB—hypothyroidism	0.000496	0.00186	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—THRB—hypothyroidism	0.000496	0.00186	CbGpPWpGaD
Tretinoin—ALDH1A1—Biological oxidations—POMC—hypothyroidism	0.000494	0.00186	CbGpPWpGaD
Tretinoin—CYP3A5—female gonad—hypothyroidism	0.00049	0.00195	CbGeAlD
Tretinoin—Vomiting—Liotrix—hypothyroidism	0.000485	0.0017	CcSEcCtD
Tretinoin—CYP2C8—testis—hypothyroidism	0.000482	0.00191	CbGeAlD
Tretinoin—Rash—Liotrix—hypothyroidism	0.000481	0.00169	CcSEcCtD
Tretinoin—Dermatitis—Liotrix—hypothyroidism	0.000481	0.00169	CcSEcCtD
Tretinoin—Headache—Liotrix—hypothyroidism	0.000478	0.00168	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—TPO—hypothyroidism	0.000466	0.00175	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—TPO—hypothyroidism	0.000466	0.00175	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—TPO—hypothyroidism	0.000466	0.00175	CbGpPWpGaD
Tretinoin—CYP2C8—liver—hypothyroidism	0.000455	0.00181	CbGeAlD
Tretinoin—Nausea—Liotrix—hypothyroidism	0.000453	0.00159	CcSEcCtD
Tretinoin—CYP4A11—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000438	0.00165	CbGpPWpGaD
Tretinoin—CYP2B6—testis—hypothyroidism	0.000432	0.00172	CbGeAlD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000432	0.00162	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000432	0.00162	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—THRA—hypothyroidism	0.000431	0.00162	CbGpPWpGaD
Tretinoin—CYP1A1—liver—hypothyroidism	0.00042	0.00167	CbGeAlD
Tretinoin—CYP4A11—NRF2 pathway—SLC5A5—hypothyroidism	0.000411	0.00154	CbGpPWpGaD
Tretinoin—CYP3A5—liver—hypothyroidism	0.000411	0.00163	CbGeAlD
Tretinoin—CYP2B6—liver—hypothyroidism	0.000408	0.00162	CbGeAlD
Tretinoin—CYP2C9—liver—hypothyroidism	0.000404	0.00161	CbGeAlD
Tretinoin—RXRA—Generic Transcription Pathway—THRA—hypothyroidism	0.000401	0.00151	CbGpPWpGaD
Tretinoin—CYP3A4—blood—hypothyroidism	0.000394	0.00157	CbGeAlD
Tretinoin—RXRG—Gene Expression—THRA—hypothyroidism	0.000394	0.00148	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—THRA—hypothyroidism	0.000386	0.00145	CbGpPWpGaD
Tretinoin—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000383	0.00144	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—NKX2-5—hypothyroidism	0.000381	0.00143	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—THRA—hypothyroidism	0.00037	0.00139	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—THRA—hypothyroidism	0.00037	0.00139	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—IGF1—hypothyroidism	0.000367	0.00138	CbGpPWpGaD
Tretinoin—CYP4A11—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000355	0.00133	CbGpPWpGaD
Tretinoin—RXRA—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000347	0.00131	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—IGF1—hypothyroidism	0.000345	0.0013	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—THRB—hypothyroidism	0.000344	0.00129	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—SLC5A5—hypothyroidism	0.000326	0.00122	CbGpPWpGaD
Tretinoin—CYP2C18—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00031	0.00117	CbGpPWpGaD
Tretinoin—CYP3A4—liver—hypothyroidism	0.000308	0.00123	CbGeAlD
Tretinoin—RARG—Gene Expression—NKX2-5—hypothyroidism	0.000307	0.00115	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—ZNF764—hypothyroidism	0.0003	0.00113	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000286	0.00107	CbGpPWpGaD
Tretinoin—RXRA—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000282	0.00106	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—NKX2-5—hypothyroidism	0.000281	0.00105	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—THRB—hypothyroidism	0.000278	0.00104	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—NKX2-5—hypothyroidism	0.000275	0.00103	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000265	0.000995	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—NKX2-5—hypothyroidism	0.000264	0.000991	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—NKX2-5—hypothyroidism	0.000264	0.000991	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000261	0.000981	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—THRB—hypothyroidism	0.000258	0.00097	CbGpPWpGaD
Tretinoin—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000255	0.000956	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000254	0.000954	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—THRB—hypothyroidism	0.000254	0.000954	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—THRB—hypothyroidism	0.000249	0.000935	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—THRB—hypothyroidism	0.000239	0.000897	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—THRB—hypothyroidism	0.000239	0.000897	CbGpPWpGaD
Tretinoin—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000233	0.000877	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—IYD—hypothyroidism	0.000223	0.000836	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—SLC5A5—hypothyroidism	0.000219	0.000822	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000216	0.000813	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—TSHB—hypothyroidism	0.000216	0.000811	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—TSHB—hypothyroidism	0.000216	0.000811	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—TSHB—hypothyroidism	0.000216	0.000811	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CLTC—hypothyroidism	0.000213	0.000801	CbGpPWpGaD
Tretinoin—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000206	0.000775	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—IYD—hypothyroidism	0.000195	0.000731	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—THRA—hypothyroidism	0.000193	0.000725	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PIK3C2A—hypothyroidism	0.000192	0.000723	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PIK3C2A—hypothyroidism	0.000192	0.000723	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PIK3C2A—hypothyroidism	0.000192	0.000723	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.00019	0.000713	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.00019	0.000713	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ATP5O—hypothyroidism	0.000189	0.000711	CbGpPWpGaD
Tretinoin—CYP2A6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000189	0.000711	CbGpPWpGaD
Tretinoin—CYP4A11—Biological oxidations—POMC—hypothyroidism	0.000189	0.000709	CbGpPWpGaD
Tretinoin—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000188	0.000707	CbGpPWpGaD
Tretinoin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000184	0.000691	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—IGF1—hypothyroidism	0.00018	0.000676	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—TPO—hypothyroidism	0.000178	0.000668	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—IYD—hypothyroidism	0.000177	0.000663	CbGpPWpGaD
Tretinoin—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000174	0.000653	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ATP5O—hypothyroidism	0.000165	0.000621	CbGpPWpGaD
Tretinoin—CYP2C18—Biological oxidations—POMC—hypothyroidism	0.000165	0.000619	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000165	0.000619	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—SLC5A5—hypothyroidism	0.000162	0.000607	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—SLC5A5—hypothyroidism	0.000162	0.000607	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—SLC5A5—hypothyroidism	0.000162	0.000607	CbGpPWpGaD
Tretinoin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000159	0.000599	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—TPO—hypothyroidism	0.000156	0.000584	CbGpPWpGaD
Tretinoin—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000153	0.000573	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ATP5O—hypothyroidism	0.00015	0.000564	CbGpPWpGaD
Tretinoin—RXRA—Biological oxidations—POMC—hypothyroidism	0.00015	0.000562	CbGpPWpGaD
Tretinoin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000149	0.00056	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—TPO—hypothyroidism	0.000141	0.00053	CbGpPWpGaD
Tretinoin—CYP1A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000141	0.000529	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NKX2-5—hypothyroidism	0.000138	0.000517	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000132	0.000497	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000131	0.000491	CbGpPWpGaD
Tretinoin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00013	0.000487	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—IYD—hypothyroidism	0.000129	0.000486	CbGpPWpGaD
Tretinoin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000129	0.000485	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—THRB—hypothyroidism	0.000124	0.000467	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—IYD—hypothyroidism	0.000119	0.000445	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ATP5O—hypothyroidism	0.00011	0.000413	CbGpPWpGaD
Tretinoin—CYP3A7—Biological oxidations—POMC—hypothyroidism	0.00011	0.000412	CbGpPWpGaD
Tretinoin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000105	0.000395	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000104	0.000392	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TPO—hypothyroidism	0.000103	0.000388	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ATP5O—hypothyroidism	0.000101	0.000379	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VAV3—hypothyroidism	0.0001	0.000377	CbGpPWpGaD
Tretinoin—CYP2A6—Biological oxidations—POMC—hypothyroidism	0.0001	0.000377	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—IYD—hypothyroidism	9.56e-05	0.000359	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TPO—hypothyroidism	9.48e-05	0.000356	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—IYD—hypothyroidism	9.35e-05	0.000351	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—IYD—hypothyroidism	8.83e-05	0.000332	CbGpPWpGaD
Tretinoin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8.55e-05	0.000321	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—POMC—hypothyroidism	8.45e-05	0.000318	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—POMC—hypothyroidism	8.45e-05	0.000318	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—POMC—hypothyroidism	8.45e-05	0.000318	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—TSHB—hypothyroidism	8.24e-05	0.000309	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—AVP—hypothyroidism	8.22e-05	0.000309	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ATP5O—hypothyroidism	8.13e-05	0.000305	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—POMC—hypothyroidism	8.11e-05	0.000305	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—IYD—hypothyroidism	8.1e-05	0.000304	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ATP5O—hypothyroidism	7.95e-05	0.000299	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—POMC—hypothyroidism	7.92e-05	0.000298	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TPO—hypothyroidism	7.65e-05	0.000287	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ATP5O—hypothyroidism	7.51e-05	0.000282	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—POMC—hypothyroidism	7.49e-05	0.000281	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TPO—hypothyroidism	7.47e-05	0.000281	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3C2A—hypothyroidism	7.34e-05	0.000276	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.24e-05	0.000272	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—TSHB—hypothyroidism	7.2e-05	0.00027	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TPO—hypothyroidism	7.06e-05	0.000265	CbGpPWpGaD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.93e-05	0.000261	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ATP5O—hypothyroidism	6.88e-05	0.000259	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—POMC—hypothyroidism	6.86e-05	0.000258	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—IYD—hypothyroidism	6.59e-05	0.000248	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.54e-05	0.000246	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—TSHB—hypothyroidism	6.53e-05	0.000245	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TPO—hypothyroidism	6.47e-05	0.000243	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3C2A—hypothyroidism	6.42e-05	0.000241	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—SLC5A5—hypothyroidism	6.17e-05	0.000232	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6e-05	0.000225	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3C2A—hypothyroidism	5.82e-05	0.000219	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.74e-05	0.000216	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ATP5O—hypothyroidism	5.6e-05	0.00021	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—POMC—hypothyroidism	5.59e-05	0.00021	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—SLC5A5—hypothyroidism	5.39e-05	0.000202	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TPO—hypothyroidism	5.27e-05	0.000198	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SLC5A5—hypothyroidism	4.89e-05	0.000184	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.88e-05	0.000183	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TSHB—hypothyroidism	4.79e-05	0.00018	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TSHB—hypothyroidism	4.39e-05	0.000165	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—IYD—hypothyroidism	4.35e-05	0.000163	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	4.27e-05	0.00016	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3C2A—hypothyroidism	3.91e-05	0.000147	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ATP5O—hypothyroidism	3.7e-05	0.000139	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—POMC—hypothyroidism	3.68e-05	0.000138	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC5A5—hypothyroidism	3.58e-05	0.000135	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TSHB—hypothyroidism	3.54e-05	0.000133	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TPO—hypothyroidism	3.47e-05	0.000131	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TSHB—hypothyroidism	3.46e-05	0.00013	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC5A5—hypothyroidism	3.28e-05	0.000123	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TSHB—hypothyroidism	3.27e-05	0.000123	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—POMC—hypothyroidism	3.23e-05	0.000121	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	3.15e-05	0.000119	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	3.08e-05	0.000116	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TSHB—hypothyroidism	3e-05	0.000113	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3C2A—hypothyroidism	2.91e-05	0.000109	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.87e-05	0.000108	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—POMC—hypothyroidism	2.82e-05	0.000106	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	2.67e-05	0.0001	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC5A5—hypothyroidism	2.65e-05	9.95e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.64e-05	9.9e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC5A5—hypothyroidism	2.59e-05	9.73e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—POMC—hypothyroidism	2.56e-05	9.61e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC5A5—hypothyroidism	2.45e-05	9.19e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TSHB—hypothyroidism	2.44e-05	9.16e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC5A5—hypothyroidism	2.24e-05	8.43e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	2.17e-05	8.17e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.14e-05	8.06e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—POMC—hypothyroidism	1.87e-05	7.04e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC5A5—hypothyroidism	1.83e-05	6.86e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—POMC—hypothyroidism	1.72e-05	6.45e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TSHB—hypothyroidism	1.61e-05	6.04e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.43e-05	5.39e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—POMC—hypothyroidism	1.39e-05	5.21e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—POMC—hypothyroidism	1.36e-05	5.09e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—POMC—hypothyroidism	1.28e-05	4.81e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.2e-05	4.52e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—POMC—hypothyroidism	1.17e-05	4.41e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—POMC—hypothyroidism	9.55e-06	3.59e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—POMC—hypothyroidism	6.3e-06	2.37e-05	CbGpPWpGaD
